2008
DOI: 10.1016/j.neulet.2008.02.065
|View full text |Cite
|
Sign up to set email alerts
|

Alteration of muscarinic and purinergic receptors in urinary bladder of rats with cyclophosphamide-induced interstitial cystitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
16
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 24 publications
(21 citation statements)
references
References 23 publications
4
16
0
Order By: Relevance
“…The CYP treatment compared with the sham treatment caused a significant (36%) decrease in B max for specific [ 3 H]NMS binding in the rat bladder, with little effect on the K d (Table ). This was consistent with our previous findings . Moreover, there was little change in the K d or B max for specific [ 3 H]NMS binding in the submaxillary gland, suggesting a specific downregulation of bladder muscarinic receptors.…”
Section: Resultssupporting
confidence: 93%
See 2 more Smart Citations
“…The CYP treatment compared with the sham treatment caused a significant (36%) decrease in B max for specific [ 3 H]NMS binding in the rat bladder, with little effect on the K d (Table ). This was consistent with our previous findings . Moreover, there was little change in the K d or B max for specific [ 3 H]NMS binding in the submaxillary gland, suggesting a specific downregulation of bladder muscarinic receptors.…”
Section: Resultssupporting
confidence: 93%
“…The radioligand binding assays for muscarinic and P2X receptors were performed using [ 3 H]NMS and [ 3 H] αβ ‐MeATP as previously described . In the [ 3 H]NMS binding assay, the tissue homogenates was incubated with different concentrations (0.06–1.0 nM) of [ 3 H]NMS in 30 mM Na + /HEPES buffer (pH 7.5).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The study found that A-317491 and another nonselective purinergic receptor antagonist, PPADS (pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonate), were effective in ameliorating the detrusor overactivity. Another study supported these findings [28]. …”
Section: Purinergic Signaling In Interstitial Cystitis/painful Bladdesupporting
confidence: 56%
“…Previous studies have implied that urinary cytokines or chemokines are involved in CYP-induced cystitis (4) and in patients with cystitis (5). We recently showed that treatment with CYP or hydrochloric acid caused a decrease in the number of muscarinic and purinergic receptors in the rat bladder (6,7). Therefore, urinary cytokines and pharmacologically relevant bladder receptors may serve as direct therapeutic targets or potential biomarkers for the development of targeted therapy designed to prevent chronic bladder inflammatory conditions such as IC.…”
Section: Introductionmentioning
confidence: 99%